Why the study?
Does Thrombotest improve the stability of control of anticoagulant therapy compared to Quick's one-stage prothrombin time in patients receiving anticoagulants?
Population
Patients receiving anticoagulant therapy
Comparison
Thrombotest for monitoring anticoagulant therapy vs Quick's one-stage prothrombin time
Design
Case_series
Authors
Loading...
Thrombotest shows no stability advantage over Quick test in this case report; leaves open whether technical benefits justify routine adoption.
Does Thrombotest improve the stability of control of anticoagulant therapy compared to Quick's one-stage prothrombin time in patients receiving anticoagulants?
Thrombotest provides technical simplicity and inter-laboratory comparability for monitoring anticoagulation, but does not improve stability of control compared to the Quick test.
Miller et al. (1964) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: